MOLECULAR MARKER TESTING AND REPORTING COMPLETENESS FOR ADULT-TYPE DIFFUSE GLIOMAS IN THE UNITED STATES
Publication
, Conference
Neff, C; Cioffi, G; Waite, K; Kruchko, C; Barnholtz-Sloan, J; Ostrom, Q; Iorgulescu, B
Published in: NEURO-ONCOLOGY
2022
Duke Scholars
Published In
NEURO-ONCOLOGY
EISSN
1523-5866
ISSN
1522-8517
Publication Date
2022
Volume
24
Start / End Page
9 / 9
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1109 Neurosciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Neff, C., Cioffi, G., Waite, K., Kruchko, C., Barnholtz-Sloan, J., Ostrom, Q., & Iorgulescu, B. (2022). MOLECULAR MARKER TESTING AND REPORTING COMPLETENESS FOR ADULT-TYPE DIFFUSE GLIOMAS IN THE UNITED STATES. In NEURO-ONCOLOGY (Vol. 24, pp. 9–9).
Neff, Corey, Gino Cioffi, Kristin Waite, Carol Kruchko, Jill Barnholtz-Sloan, Quinn Ostrom, and Bryan Iorgulescu. “MOLECULAR MARKER TESTING AND REPORTING COMPLETENESS FOR ADULT-TYPE DIFFUSE GLIOMAS IN THE UNITED STATES.” In NEURO-ONCOLOGY, 24:9–9, 2022.
Neff C, Cioffi G, Waite K, Kruchko C, Barnholtz-Sloan J, Ostrom Q, et al. MOLECULAR MARKER TESTING AND REPORTING COMPLETENESS FOR ADULT-TYPE DIFFUSE GLIOMAS IN THE UNITED STATES. In: NEURO-ONCOLOGY. 2022. p. 9–9.
Neff, Corey, et al. “MOLECULAR MARKER TESTING AND REPORTING COMPLETENESS FOR ADULT-TYPE DIFFUSE GLIOMAS IN THE UNITED STATES.” NEURO-ONCOLOGY, vol. 24, 2022, pp. 9–9.
Neff C, Cioffi G, Waite K, Kruchko C, Barnholtz-Sloan J, Ostrom Q, Iorgulescu B. MOLECULAR MARKER TESTING AND REPORTING COMPLETENESS FOR ADULT-TYPE DIFFUSE GLIOMAS IN THE UNITED STATES. NEURO-ONCOLOGY. 2022. p. 9–9.
Published In
NEURO-ONCOLOGY
EISSN
1523-5866
ISSN
1522-8517
Publication Date
2022
Volume
24
Start / End Page
9 / 9
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1109 Neurosciences